Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
303 hedge funds and large institutions have $5.73B invested in Abiomed Inc in 2017 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 126 increasing their positions, 100 reducing their positions, and 21 closing their positions.
135% more call options, than puts
Call options by funds: $18.7M | Put options by funds: $7.93M
95% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 21
71% more funds holding in top 10
Funds holding in top 10: 7 → 12 (+5)
26% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 100
13% more capital invested
Capital invested by funds: $5.07B → $5.73B (+$663M)
6% more funds holding
Funds holding: 287 → 303 (+16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$64.3M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$40.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.6M |
| 4 |
Renaissance Technologies
New York
|
+$30.2M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$21.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$103M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$54M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$47.1M |
| 4 |
Primecap Management
Pasadena,
California
|
-$27.2M |
| 5 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$26.3M |
ABMD Hedge Fund Activity: Q2 2017 in Review
303 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2017, worth a combined $5.73B — up 13% from $5.07B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new ABMD positions and 21 closed out — a net gain of 20 holders — while 126 added to existing stakes and 100 trimmed.
The largest buyer was Brown Capital Management, adding an estimated $64.3M. The largest seller was Wellington Management Group, cutting an estimated $103M.
- 303 institutional investors held Abiomed Inc (ABMD) as of Q2 2017, up from 287 in Q1 2017.
- Funds reported $5.73B of Abiomed Inc stock for Q2 2017, up 13% quarter-over-quarter.
- 41 funds opened new Abiomed Inc positions in Q2 2017 and 21 closed out, a net change of +20 holders.
- The largest Abiomed Inc buyer in Q2 2017 was Brown Capital Management, an estimated $64.3M added.
- The largest Abiomed Inc seller in Q2 2017 was Wellington Management Group, an estimated $103M sold.
Based on aggregated 13F filings for Q2 2017.